Skip to content

Intrathecal Morphine in Robot-assisted Prostatectomy

The Efficacy of Intrathecal Morphine in Patients Undergoing Robot-assisted Prostatectomy

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01991275
Acronym
RoboITMProst
Enrollment
30
Registered
2013-11-25
Start date
2013-11-30
Completion date
2014-06-30
Last updated
2015-07-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Prostatic Neoplasms

Keywords

Prostatic Neoplasms, Laparoscopy, Injections, Spinal, Morphine

Brief summary

This study will investigate the efficacy and safety of intrathecal morphine for the patients undergoing robot-assisted prostatectomy

Detailed description

Prostatectomy is the treatment of choice for prostate cancer. The robot-assisted prostatectomy is becoming the most popular surgical method for prostate cancer. The small incision after robot-assisted prostatectomy is thought to reduce the postoperative pain. There is few investigations for the strategy to reduce the postoperative pain of robot-assisted prostatectomy. The intrathecal morphine injection is known to reduce postoperative pain for surgeries like hepatectomy, myomectomy and open prostatectomy. This method, however, is not yet studied for the robot-assisted prostatectomy. This study will investigate the efficacy and safety of intrathecal morphine for the patients undergoing robot-assisted prostatectomy.

Interventions

The intravenous injection of morphine using the patient-controlled analgesia machine

A single injection of morphine intrathecally

Sponsors

Seoul National University Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
19 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

* Patients scheduled for the open nephrectomy

Exclusion criteria

* Patients with renal insufficiency * Patients with coagulopathy * History of any neurologic disorder * History of recent infection in 2 weeks * History of drug abuse * Patients who cannot understand the usage of th intravenous patient-controlled analgesia * Patients using opioids due to the chronic pain

Design outcomes

Primary

MeasureTime frameDescription
The evaluation of pain at 24 hours after surgeryat postoperatively 24 hoursThe doctor blinded to the investigation will visit patients. The pain will be assessed at rest and at coughing using visual analogue scale.

Secondary

MeasureTime frameDescription
The consumption of analgesicsat postoperatively 24 hoursThe total amount of opioids (IV morphine) used for 24 hours after surgery will be recorded and compared.
The consumption of intraoperative opioidsFrom the induction of anesthesia till the emergence of anesthesia, an expected average of 4 hoursThe total amount of intraoperative opioids (IV remifentanil) will be recorded and compared.
The side effects of opioids after surgeryDuring 72 hours after the end of surgeryAny side effects of opioids including nausea, vomiting, dizziness, sedation, headache, pruritus and respiratory depression will be recorded.

Countries

South Korea

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026